Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Advancing Patient Care with Antibody-Drug Conjugate Therapies in HER2-Negative and HER2-Low Metastatic Breast Cancer : Episode 14
Opinion
Video
Discussing ADC Risks, Benefits, and Regimens With Patients
Panelists discuss how health care professionals use clear, tailored communication to explain antibody-drug conjugate (ADC) risks, benefits, and regimens. They provide education, address concerns, and ensure adherence through counseling and shared decision-making.
Video content above has been prompted by the following:
- At your institution, how do you effectively communicate with patients about ADC therapies (eg, risks, benefits, treatment regimens)?
Related Videos
Related Content
